READ RELATED ARTICLES

CGM Overview with TCOYD
Dexcom G7 FDA Approved
“Dexcom G7 CGM: Next Gen Gets FDA Clearance!”
READ ARTICLE
FreeStyle Libre 3 FDA Approval
“The World’s Smallest CGM Gets FDA Approval, and Bigger Isn’t Always Better!”
READ ARTICLE
Dr. Edelman's Eversense E3 CGM Review
“My Review of the FDA-Approved Eversense E3 CGM”
READ ARTICLE

READ RELATED ARTICLES

PUMPS/HCL Systems with TCOYD
“2023 Diabetes Highlights: Better Health Ahead!”
READ ARTICLE
Pumps for Type 2
“The Benefits and Barriers of Insulin Pump Therapy in Type 2 Diabetes”
READ ARTICLE
“DIY Looping VS Control-IQ”
READ ARTICLE

LISTEN TO RELATED PODCASTS

ACCESS YOUR DIABETES CARE

DexCom, Inc. empowers people to take real-time control of health through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, Calif., and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom works to simplify and improve diabetes management around the world. For more information about Dexcom CGM, visit www.dexcom.com.

Medtronic Diabetes is on a mission to alleviate the burden of diabetes by empowering individuals to live life on their terms, with the most advanced technology and always-on support when and how it is needed. Medtronic has pioneered first-of-its-kind innovations for over 40 years and is committed to designing the future of diabetes management through next-generation sensors (CGM), intelligent dosing systems, and the power of data science and AI while always putting the customer experience at the forefront. Today we offer the MiniMed™ 780G insulin pump system, the InPen™ smart insulin pen and the i-Port Advance™ injection port, and we continue to innovate further. With a renewed focus on creating products that are easy to use, we hope our future technologies will enable people to focus more on life, and not diabetes. To learn more, visit medtronicdiabetes.com and follow us on Facebook, Instagram, TikTok, YouTube and LinkedIn.

The Eversense CGM System provides continuous glucose monitoring for up to 6 months via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. If you’re on insulin, discover what Eversense can do for you.

We’re helping people with diabetes lead healthier, happier lives.

As a global leader in diabetes care, Abbott is constantly working to deliver the highest quality products and unwavering support to our customers. Consistent and accurate glucose monitoring is the foundation of any diabetes management plan so we’re committed to continuous improvement in the way patients and professionals measure, track and analyze glucose levels.

Trying to keep your blood sugar in range can be stressful and time consuming, but thanks to the t:slim X2™ insulin pump with Control-IQ® advanced hybrid closed-loop technology, it now can be easier. Our community is raving about how the t:slim X2™ insulin pump with Control-IQ® technology does more than change routines, it changes lives!